Skip to content

Epileptology and NeuroPalliativeCare: Seizures in End of Life

Epileptology and NeuroPalliativeCare: Seizures in End of Life - EPIxPAL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00031864
Enrollment
580
Registered
2023-05-12
Start date
2023-05-30
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with incurable, advanced diseases with epileptic seizures and palliative care needs.

Interventions

Group 1: Palliative care physicians working in inpatient and outpatient palliative care in Berlin
all palliative care physicians working in specialized inpatient and outpatient palliative care in Berlin are asked to take part in the online-survey. Group 2: Palliative care physicians working in inp
physicians who have specialized in palliative care and who are working in specialized inpatient and outpatient palliative care in Germany are asked to take part in the online-survey. Group 3: DELPHI-P
nationwide experts are invited.

Sponsors

Charité - Universitätsmedizin Berlin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: physicians specialized in palliative care

Exclusion criteria

Exclusion criteria: I) No board examination in palliative care. Less than 1 year of practical experience in palliative care.

Design outcomes

Primary

MeasureTime frame
Subject of this study is the survey of treatment processes and practice for epileptic seizures in inpatient and outpatient palliative care. The primary aim of the study is to evaluate the proportion of palliative patients with epileptic seizures in inpatient and outpatient palliative care (palliative care ward, palliative care consultation service, hospice, SOPV), detect challenges for palliative care professionals in the treatment of epileptic seizures, determination of the drug treatment practice, frequency of changing antiseizure medication at the end of life, frequency of the indication of palliative sedation due to series of seizures that are difficult to control or pharmacoresistant status epilepticus.

Secondary

MeasureTime frame
Secondary research goal is the development of guidelines for the treatment of epileptic seizures in the context of specialized inpatient and outpatient palliative care using a Germany-wide Delphi process.

Countries

Germany

Contacts

Public ContactAnna-Christin Willert

Charité - Universitätsmedizin Berlin

EPIxPAL@charite.de+49 450 660 599

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026